| Q40791226 | 6p abnormalities and TNF-alpha over-expression in retinoblastoma cell line |
| Q36301276 | A Novel Retinoblastoma Protein (RB) E3 Ubiquitin Ligase (NRBE3) Promotes RB Degradation and Is Transcriptionally Regulated by E2F1 Transcription Factor |
| Q34631552 | A continuum model for tumour suppression |
| Q53630492 | A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma. |
| Q44024295 | A prospective study of children treated for retinoblastoma: cognitive and visual outcomes in relation to treatment. |
| Q69907555 | Analysis of 13q RFLP in multiple endocrine neoplasia type II kindreds |
| Q45108358 | Analysis of KLLN as a high-penetrance breast cancer predisposition gene |
| Q53542695 | Anti-oncogenes. A subset of regulatory genes involved in carcinogenesis? |
| Q33596814 | Application of PCR amplification of DNA from paraffin embedded tissue sections to linkage analysis in familial retinoblastoma |
| Q39697849 | Applications of monoclonal antibodies in the investigation, diagnosis, and treatment of retinoblastoma |
| Q35227313 | Approaches to proto-oncogene and tumour suppressor gene identification |
| Q34660343 | Assessing the effects of metabolism of environmental agents on cancer tumor development by a two-stage model of carcinogenesis |
| Q74622856 | Cell biology of precancer |
| Q39180520 | Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies |
| Q33830472 | Chemical carcinogenesis: too many rodent carcinogens |
| Q39745164 | Chromosomal changes in secondary leukemias of childhood and young adulthood |
| Q59093916 | Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping |
| Q41445205 | Clinical applications of tumor suppressor genes and oncogenes in cancer |
| Q36467753 | Clonal allele loss in gastrointestinal cancers |
| Q26774786 | Concise Review: Patient-Specific Stem Cells to Interrogate Inherited Eye Disease |
| Q58862299 | Constitutional deletions predisposing to retinoblastoma |
| Q46575531 | Constitutional p53 mutations associated with brain tumors in young adults |
| Q34840499 | DNA lesions, inducible DNA repair, and cell division: three key factors in mutagenesis and carcinogenesis |
| Q39502026 | Diagnosis of genetic disease using recombinant DNA. |
| Q36634188 | Dissociation of retinoblastoma gene protein hyperphosphorylation and commitment to enter S phase |
| Q34787097 | Distinct requirements for Ras oncogenesis in human versus mouse cells |
| Q54041756 | Environmental causes of cancer. |
| Q54105069 | Estrogen-induced rat pituitary tumor is associated with loss of retinoblastoma susceptibility gene product. |
| Q28284637 | Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene |
| Q58862231 | Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas |
| Q36028393 | Generation of loss of heterozygosity and its dependency on p53 status in human lymphoblastoid cells |
| Q38138544 | Genetic and epigenetic losses of heterozygosity in cancer predisposition and progression |
| Q33648550 | Genetic counselling in retinoblastoma: importance of ocular fundus examination of first degree relatives and linkage analysis |
| Q35199262 | Genetic mechanisms of tumor-specific loss of 11p DNA sequences in Wilms tumor |
| Q35560459 | Genetics and molecular biology of telomeres |
| Q40835798 | Genetics of cancer predisposition and progression |
| Q44361321 | Genomic alterations in human breast carcinomas |
| Q40864844 | Genomic changes in glioblastoma cell lines detected by comparative genomic hybridization |
| Q34601019 | Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice |
| Q33196614 | High-resolution analysis of genetic events in cancer cells using bacterial artificial chromosome arrays and comparative genome hybridization |
| Q41155767 | High-resolution mapping of heteroduplex DNA formed during UV-induced and spontaneous mitotic recombination events in yeast |
| Q37371276 | How the Rb tumor suppressor structure and function was revealed by the study of Adenovirus and SV40. |
| Q29620382 | Identification and characterization of the familial adenomatous polyposis coli gene |
| Q34838128 | Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis |
| Q36260162 | In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma |
| Q33570260 | Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families |
| Q36152246 | Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer |
| Q41236837 | Interphase cytogenetic analysis of solid tumors by non-isotopic DNA in situ hybridization |
| Q69446171 | Interstitial deletion of chromosome 13 involving the region 13q14 |
| Q36919850 | Levels of fos, ets2, and myb proto-oncogene RNAs correlate with segregation of chromosome 11 of normal cells and with suppression of tumorigenicity in human cell hybrids |
| Q40624222 | Localization and identification of the multiple endocrine neoplasia type 1 disease gene. |
| Q37401701 | Localization of a lymphocyte-specific protein tyrosine kinase gene (lck) at a site of frequent chromosomal abnormalities in human lymphomas |
| Q24558744 | Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors |
| Q30502324 | Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression |
| Q59077568 | Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma |
| Q34614026 | Loss of heterozygosity in human ductal breast tumors indicates a recessive mutation on chromosome 13 |
| Q59053447 | Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism |
| Q30502393 | Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung |
| Q68740851 | Malignant tumours generated by recessive mutations |
| Q69692275 | Measurements of the frequency of human erythrocytes with gene expression loss phenotypes at the glycophorin A locus |
| Q35977782 | Mechanisms of oncogenesis in patients with familial retinoblastoma |
| Q34485665 | Mechanisms underlying losses of heterozygosity in human colorectal cancers |
| Q57791050 | Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization |
| Q36469423 | Molecuar biology of hepatocellular carcinoma and hepatitis B virus association |
| Q40468269 | Molecular Genetics and Cytogenetics of Sarcomas |
| Q39701871 | Molecular genetic approaches to the analysis of human ophthalmic disease |
| Q36476823 | Molecular genetics in the pathology and diagnosis of retinoblastoma |
| Q34051118 | Molecular insight into medulloblastoma and central nervous system primitive neuroectodermal tumor biology from hereditary syndromes: a review |
| Q43737604 | Molecular nature of chromosome 5q loss in colorectal tumors and desmoids from patients with familial adenomatous polyposis |
| Q36553814 | Mouse mammary tumor virus/v-Ha-ras transgene-induced mammary tumors exhibit strain-specific allelic loss on mouse chromosome 4 |
| Q48100816 | Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma |
| Q35227325 | Multistage carcinogenesis in paediatric and adult cancers |
| Q40951665 | Mutation and cancer: a personal odyssey |
| Q36794281 | Mutations in the RB1 gene and their effects on transcription |
| Q42834984 | Neoplastic transformation and tumorigenesis associated with sam68 protein deficiency in cultured murine fibroblasts |
| Q35199056 | Nonrandom loss of maternal chromosome 11 alleles in Wilms tumors |
| Q40884064 | Oncogenes and ENT: a review of the molecular biological advances in squamous cell carcinoma of the head and neck |
| Q35662775 | Oncogenes and tumor suppressor genes: new biochemical tests |
| Q37542430 | Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition |
| Q34597551 | Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas |
| Q53010646 | Parallel genome analysis by one- and two-dimensional DNA fingerprinting in human gliomas. |
| Q40559871 | Pathogenesis of pituitary Cushing's syndrome. Pituitary versus hypothalamic. |
| Q68959323 | Protooncogene abnormalities in colon cancers and adenomatous polyps |
| Q53665221 | Putative tumor-suppressor gene regions responsible for radiation lymphomagenesis in F1 mice with different p53 status. |
| Q36579239 | RB, the conductor that orchestrates life, death and differentiation |
| Q36458932 | RB116: an RB1+ retinoblastoma cell line expressing primitive markers. |
| Q40875928 | Radiation specific patterns of loss of heterozygosity on chromosome 17q. |
| Q36468738 | Recessive Mutations in Cancer Predisposition and Progression |
| Q33889285 | Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation |
| Q58078776 | Retinoblastoma Protein Expression and Prognosis in Laryngeal Cancer |
| Q40970798 | Retinoblastoma cells activate the AKT pathway and are vulnerable to the PI3K/mTOR inhibitor NVP-BEZ235. |
| Q71834697 | Retinoblastoma protein in human breast carcinoma: immunohistochemical study using a new monoclonal antibody effective on routinely processed tissues |
| Q34153888 | Retinoblastoma tumor suppressor and genome stability |
| Q39094351 | Roles of pRB in the Regulation of Nucleosome and Chromatin Structures. |
| Q42037982 | Somatic intragenic recombination within the mutated locus BLM can correct the high sister-chromatid exchange phenotype of Bloom syndrome cells. |
| Q35730030 | Spatiotemporal Patterns of Tumor Occurrence in Children with Intraocular Retinoblastoma |
| Q36659274 | Specific enzymatic dephosphorylation of the retinoblastoma protein |
| Q39763722 | Suppression of the neoplastic phenotype and "anti-oncogenes". |
| Q34040108 | Tailoring to RB: tumour suppressor status and therapeutic response |
| Q40873279 | The gene as theme in the paradigm of cancer |
| Q70117697 | The genetics of retinoblastoma |
| Q35889146 | The genetics of retinoblastoma, revisited |
| Q37671253 | The genetics of retinoblastoma. Relevance to the patient |
| Q41194136 | The genotype of the human cancer cell: implications for risk analysis. |
| Q39145519 | The molecular genetics of retinoblastoma and Wilms' tumor |
| Q37786131 | The recessive mutational concept of oncogenesis |
| Q35563106 | The recessive nature of dominance |
| Q40696376 | The retinoblastoma gene and its significance |
| Q39628604 | The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression |
| Q36026757 | The search for the retinoblastoma cell of origin |
| Q53376250 | The significance of unstable chromosomes in colorectal cancer. |
| Q35563096 | The two‐hit model for Wilms' tumor: Where are we 30 years later? |
| Q37272653 | The von Hippel-Lindau gene: turning discovery into therapy |
| Q36356124 | Transformation of human kidney proximal tubule cells by ras-containing retroviruses. Implications for tumor progression |
| Q34322858 | Tumor suppression involves down-regulation of interleukin 3 expression in hybrids between autocrine mastocytoma and interleukin 3-dependent parental mast cells |
| Q37289549 | Tumor suppressor genes and cancer of the human nervous system |
| Q40568049 | Tumor suppressor genes and their roles in breast cancer |
| Q33853617 | Tumor-specific loss of 11p15.5 alleles in del11p13 Wilms tumor and in familial adrenocortical carcinoma |
| Q48311505 | Tumour induction by the retinoblastoma mutation is independent of N-myc expression. |
| Q38232206 | Tumour suppressor genes: oncogenesis update |
| Q91651435 | p53: a tumor suppressor hiding in plain sight |